LEMC
LJMH
SC
FZ
SB
AMPersonalised emails written for every contact · 97% deliverability · live in 60 seconds
| Company | What they do | Location | Size | Hiring |
|---|---|---|---|---|
Neumoraneumoratx.com RL  ZKMC |
Neumora Therapeutics is a precision neuroscience company developing novel therapies for brain diseases, including neuropsychiatric | Watertown, Massachusetts | 51-200 | — |
Aperture Therapeuticsaperturetx.com  MV MJ |
Aperture Therapeutics is a biotechnology company developing a new class of therapeutics to treat injury- and age-induced neurodege | San Carlos, California | 1-10 | — |
Cerevel Therapeuticscerevel.com |
Cerevel Therapeutics is a biopharmaceutical company developing drugs to treat neurological and neuropsychiatric disorders, founded | Cambridge, Massachusetts | 201-1000 | — |
Biomedisynbiomedisyn.com  PSFV |
Biomedisyn is a biopharmaceutical research company based in Woodbridge, Connecticut, engaged in chemical and biological research u | Woodbridge, Connecticut | 1-10 | — |
Maplightrxmaplightrx.com  AC LC JC |
MapLight Therapeutics is a biopharmaceutical company discovering and developing novel therapeutics for patients with disorders of | Redwood City, California | 51-200 | — |
Aytu BioPharmaaytubio.com FG  SK JS |
Aytu BioPharma (NASDAQ: AYTU) is a specialty biopharmaceutical company focused on advancing innovative medicines for complex centr | Denver, Colorado | 51-200 | — |
Contineum Therapeuticscontineum-tx.com |
Contineum Therapeutics (Nasdaq: CTNM) is a clinical-stage biopharmaceutical company developing oral small molecule therapies for n | San Diego, California | 51-200 | — |
Axonis Therapeuticsaxonis.us  SH YCSC |
Axonis Therapeutics is a Boston-based neuro-focused biotechnology company developing first-in-class oral KCC2 potentiator medicine | Boston, Massachusetts | 11-50 | — |
Axsome Therapeuticsaxsome.com JFKW  DP |
Axsome Therapeutics is a biopharmaceutical company developing novel CNS therapies, including AXS-05, AXS-12, and AXS-14, for condi | New York, New York | 1001-5000 | — |
BlackThorn Therapeuticsblackthornrx.com |
BlackThorn Therapeutics is a clinical-stage neurobehavioral health company based in San Francisco that is pioneering the next gene | San Francisco, California | 11-50 | — |
Karuna Therapeuticskarunatx.com |
Karuna Therapeutics is a biopharmaceutical company developing and delivering medicines for psychiatric and neurological conditions | Boston, Massachusetts | 201-1000 | — |
Alto Neurosciencealtoneuroscience.com  SL TLMB |
Alto Neuroscience is a clinical-stage biotechnology company developing biology-driven medicines for neuropsychiatric conditions, u | Mountain View, California | 51-200 | — |
Cellestial Healthcellestialhealth.com SR  NH NH |
Cellestial Health is a preclinical biopharmaceutical company developing brain-penetrant small molecule therapies that target astro | Cambridge, United Kingdom | 51-200 | — |
| Run live for more | ||||
Neumora Therapeutics is a precision neuroscience company developing novel therapies for brain diseases, including neuropsychiatric disorders and neurodegenerative diseases. Founded in 2020 and headquartered in Watertown, Massachusetts, the company raised $500 million and partners with Amgen on R&D collaboration to accelerate precision medicines for brain disorders.
Companies like Neumora include Aperture Therapeutics, Cerevel Therapeutics, Biomedisyn, Maplightrx, Aytu BioPharma. See the full list of 24 competitors and alternatives above.
Neumora has approximately 51-200 employees and is in the Biotechnology Research industry.
Neumora is headquartered in Watertown, Massachusetts.
Neumora operates in the Biotechnology Research industry.
Key decision-makers and buying contacts at Neumora are listed above, including leaders across executive, finance, sales and operations.